Ossiam Exact Sciences Corp Transaction History

Ossiam

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$41.33 - $74.26 $11,324 - $20,347	274 Added 1.39%	19,988 $844,000
Q1 2024 May 13, 2024	BUY	$56.27 - $73.77 $9,678 - $12,688	172 Added 0.88%	19,714 $1.36 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $906,279 - $1.36 Million	13,744 Added 237.05%	19,542 $1.33 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $200,701 - $304,350	3,202 Added 123.34%	5,798 $544,000
Q1 2023 May 12, 2023	BUY	$47.19 - $70.77 $8,541 - $12,809	181 Added 7.49%	2,596 $176,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $77,207 - $119,228	2,415 New	2,415 $78,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

Stay updated on Ossiam with notifications on news.